Richard A. Young

CIK: 0001490283

Transaction Breakdown

Open Market Buys (P)2 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CAMP

Camp4 Therapeutics Corp

Director

SYRS

Syros Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CAMP
Camp4 Therapeutics Corp
Aug 3, 2026
Purchase(P)
Direct
16.4K shares at avg. $1.65$27K
CAMP
Camp4 Therapeutics Corp
Jun 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
CAMP
Camp4 Therapeutics Corp
Sep 11, 2025
Purchase(P)
Direct
15.2K shares at avg. $1.65$25K
CAMP
Camp4 Therapeutics Corp
Jun 25, 2025
Award(A)
Stock Option (Right to Buy)
Direct
9K shares-
CAMP
Camp4 Therapeutics Corp
Oct 15, 2024
Conversion(C)
Direct
8.9K shares-
SYRS
Syros Pharmaceuticals, Inc.
Sep 16, 2024
Exercise(M)
Direct
2.7K shares-

		Type	Shares	Price		Ownership
Aug 3, 2026	CAMP Camp4 Therapeutics Corp	Purchase(P)	16,378	$1.65	$27,024	Direct
Jun 10, 2026	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Sep 11, 2025	CAMP Camp4 Therapeutics Corp	Purchase(P)	15,151	$1.65	$24,999	Direct
Jun 25, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	9,000	-	-	Direct
Oct 15, 2024	CAMP Camp4 Therapeutics Corp	Conversion(C)	8,917	-	$0	Direct
Sep 16, 2024	SYRS Syros Pharmaceuticals, Inc.	Exercise(M)	2,667	-	$0	Direct

1-6 of 6 transactions

About Young Richard A

Young Richard A (SEC CIK 0001490283) files insider reports with the SEC as Director of Camp4 Therapeutics Corp (CAMP) and Director of Syros Pharmaceuticals, Inc. (SYRS).

Signal8 holds 7 ownership filings by Young Richard A (1 Form 3, 6 Form 4), filed between Sep 18, 2024 and Aug 5, 2026. Those filings report 6 transactions, from Sep 16, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Young Richard A's filings is in CAMBRIDGE, MA.

Recent filings by Young Richard A

Aug 3, 2026: Open-market purchase of CAMP shares (Form 4, code P).
Jun 10, 2026: Grant or award of CAMP derivative securities (Form 4, code A).
Sep 11, 2025: Open-market purchase of CAMP shares (Form 4, code P).
Jun 25, 2025: Grant or award of CAMP derivative securities (Form 4, code A).
Oct 15, 2024: Conversion of CAMP shares (Form 4, code C).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
Tardiff Daniel, Chief Scientific Officer
5AM Partners VI, LLC, 10% Owner
Maricich Yuri, Chief Medical Officer
Mandel-Brehm Josh, Chief Executive Officer

How to read Form 4 transaction codes